Delivery Order SPE2DB22D2007-SPE2DB24FJ3CF
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of NovologTM 100 unit/mL Flexpen 3mL insulin products. The $1,703.48 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 28, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of NovOlog 100 unit/mL FlexPen 3mL, a type of insulin delivery device. The $1,092.43 firm-fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen, a large pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Novolog 100 Unit/mL FlexPen 3mL insulin products. The $1,810.80 fixed-price delivery order has a completion date of September 27, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as the primary vehicle for providing...
- This contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,037.94 firm-fixed-price delivery order is for the supply of Novolog 100 Unit/mL Flexpen 3mL, a type of insulin medication. The contract has an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $4,084.80 firm-fixed price contract is for the delivery of NovologⓇ 100 unit/mL FlexPen 3mL insulin products. The order has an ultimate completion date of May 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $3,676.32 delivery order contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has a firm fixed price pricing type and a period of performance extending through May 30, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Novolog 100 Unit/mL Flexpen 3mL insulin pens. The contract has a ceiling value of $3,111.20 and a period of performance through May 31, 2024. It is a firm fixed price delivery order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with...
- AmerisourceBergen Drug Corp was awarded a delivery order on April 24, 2025, valued at $6,707.89 for the supply of Novolog 100 Unit/mL Flexpen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order is set to be completed by April 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was issued by the Medical Supply Chain division of the Defense Logistics Agency under the federal government's medical procurement...
- This federal contract award is for the delivery of NovologTM 100 Unit/mL FlexPen® 3mL, a prescription insulin medication, to the Defense Logistics Agency (DLA). The $1,838.16 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 6, 2023. The contract has an ultimate completion date of April 7, 2023 and is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of NovologTM 100 unit/mL FlexPen 3mL, a prescription insulin medication. The fixed-price, firm-fixed-price contract has a ceiling value of $1,327.70 and an ultimate completion date of July 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ3CFDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of NovologⓇ 100 Unit/mL FlexPenⓇ 3mL insulin pens. The $1,089.28 firm fixed-price delivery order was placed by the Defense Logistics Agency, a defense agency, and has a completion date of June 5, 2024. The award is not associated with a set-aside program. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 single-award Indefinite Delivery Contract with DLA Troop Support Medical to provide a wide range of medical products and supplies to support the Department of Defense globally. The company also has a smaller $750,000 Indefinite Delivery Contract with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/4/24 |